{"id":624633,"title":"Canada Gazette Part I - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T03:39:27.275000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/canada-gazette-part-1.html","snippet":"Canada Gazette Part I The following proposed regulatory amendments and Regulatory Impact Analysis Statement ( RIAS ) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to provide comments on these proposals within the time period…","rawSnapshotUrl":"/api/snapshots/raw/624633","browseUrl":"https://replay.healtharchive.ca/job-6/20260227033927/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/legislation-guidelines/canada-gazette-part-1.html#ha_snapshot=624633","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}